Sell Glenmark Pharma, advises Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Glenmark Pharma is a short. Pharmaceutical seems to be breaking down. Yesterday or day before we have been talking and I suggested that IT, pharmaceutical and banks are all now giving signs of distribution. Banks have been doing that and these are the sectors that will lead the Nifty down. That seems to be working out. Pharmaceutical is not a buying opportunity, some stocks are actually short-term sells, some are complete avoids. Glenmark Pharma is a short-term sell."At 11:07 hrs Glenmark Pharma was quoting at Rs 878.15, down Rs 28.50, or 3.14 percent. It has touched an intraday high of Rs 900.00 and an intraday low of Rs 874.50.